
Veterinary Pharmaceutical and Medicinal Product Manufacturing in New Zealand - Industry Market Research Report
Description
Veterinary Pharmaceutical and Medicinal Product Manufacturing in New Zealand
Veterinary pharmaceutical and medicinal product manufacturers are facing mixed operating conditions. Declines in dairy cattle, sheep and deer numbers are reducing demand for veterinary pharmaceuticals. Meanwhile, rising beef cattle herd sizes and increased spending on pet health care are driving sales. Concerns over antibiotic resistance are disrupting an important source of income for veterinary pharmaceutical manufacturers. Pandemic-related supply chain issues are also causing foreign demand to fluctuate, with manufacturers that have operations overseas opting to produce there instead of exporting. Overall, revenue is expected to fall at an annualised 0.6% over the five years through 2022-23 – including a current-year increase by 0.4% – to $516.5 million, while profit has slipped to an estimated 6.6%.
Industry operators primarily manufacture drugs, medicines, medicinal chemicals, vaccines, serums and other pharmaceutical products for veterinary use.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Veterinary pharmaceutical and medicinal product manufacturers are facing mixed operating conditions. Declines in dairy cattle, sheep and deer numbers are reducing demand for veterinary pharmaceuticals. Meanwhile, rising beef cattle herd sizes and increased spending on pet health care are driving sales. Concerns over antibiotic resistance are disrupting an important source of income for veterinary pharmaceutical manufacturers. Pandemic-related supply chain issues are also causing foreign demand to fluctuate, with manufacturers that have operations overseas opting to produce there instead of exporting. Overall, revenue is expected to fall at an annualised 0.6% over the five years through 2022-23 – including a current-year increase by 0.4% – to $516.5 million, while profit has slipped to an estimated 6.6%.
Industry operators primarily manufacture drugs, medicines, medicinal chemicals, vaccines, serums and other pharmaceutical products for veterinary use.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
45 Pages
- TABLE OF CONTENTS
ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
KEY STATISTICS
Industry Data
Annual Change
Key Ratios
JARGON & GLOSSARY
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.